Shanghai Yuli Biotechnology Co., Ltd. is a trusted Contract Development and Manufacturing Organization (CDMO) in the field of global peptide drug development. The company is headquartered in Shanghai and operates a large-scale, modern production facility ccurrently aligned with GMP-like quality management systems,s, with plans to fully upgrade to cGMP standards compliant with China, the U.S., and the European Union by Q3 2026. Supported by industry-leading automated production lines and deep process expertise, we possess strong commercial-scale capacity for manufacturing up to 500 kg of peptide active pharmaceutical ingredients (APIs) per year. We are continuously working toward meeting the requirements for relevant Green/Priority Review pathways and remain committed to providing high-quality, reliable, end-to-end solutions for global partners—from preclinical stages through commercialization.